Clinical Development Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Clinical Development stocks.

Clinical Development Stocks Recent News

Date Stock Title
Jul 3 REGN Europe Approves Sanofi/Regeneron's Dupixent for 'Smoker's Lungs' A Month After US FDA Asks For Data
Jul 3 LDOS Zacks.com featured highlights include ResMed, Badger Meter, Leidos and Ingersoll Rand
Jul 3 LDOS Zacks.com featured highlights include Tenet Healthcare, Leidos Holdings, Atmos Energy and Cabot
Jul 3 REGN Regeneron (REGN), SNY Win EC Approval for Dupixent for COPD
Jul 3 REGN Sanofi, Regeneron win EU label expansion for Dupixent in COPD
Jul 3 REGN Dupixent® (dupilumab) Approved in the European Union as the First-ever Targeted Therapy for Patients with COPD
Jul 2 REGN Insider Sale: Director Arthur Ryan Sells Shares of Regeneron Pharmaceuticals Inc (REGN)
Jul 2 LDOS 4 Top Earnings Growth Stocks to Buy: RMD, BMI, LDOS, IR
Jul 2 LDOS 4 Stocks That Boast Remarkable Interest Coverage Ratio
Jul 2 REGN Insiders At Regeneron Pharmaceuticals Sold US$26m In Stock, Alluding To Potential Weakness
Jul 2 LDOS Zacks.com featured highlights include Leidos, Cabot, Williams-Sonoma, Booz Allen Hamilton and Brady
Jul 2 LDOS Defense Contractors Stocks Q1 Recap: Benchmarking Leidos (NYSE:LDOS)
Jul 1 ICLR ICON plc Schedules Second Quarter 2024 Earnings Conference Call
Jul 1 LDOS Zacks.com featured highlights include Amkor Technology, Tenet Healthcare, Leidos and Maximus
Jul 1 REGN Regeneron (REGN) Gets Positive CHMP Opinion for Lymphoma Drug
Jul 1 LDOS 5 Dividend Stocks to Pick for Solid Growth in the Second Half
Jul 1 ALNY Alnylam, Lilly, AstraZeneca among best performing pharmas, biotechs in Q2
Jun 30 ALNY Rivian Automotive And Carvana Were Among The 10 Biggest Large Cap Gainers Last Week (June 23-June 29): Are These In Your Portfolio?
Jun 29 ALNY Selling US$7.7m Of Alnylam Pharmaceuticals Stock Rewarded Insiders
Jun 28 ICLR Is Icon PLC (ICLR) a Solid Growth Stock? 3 Reasons to Think "Yes"
Clinical Development

Clinical development is the process of developing a new drug, medical device, or diagnostic test from the initial concept to the point of regulatory approval. It involves a series of steps, including preclinical research, clinical trials, regulatory review, and post-marketing surveillance. The goal of clinical development is to demonstrate the safety and efficacy of a product in order to obtain regulatory approval for marketing.

Browse All Tags